Michael L. Ganz
Harvard University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Michael L. Ganz.
Milbank Quarterly | 1998
Bruce G. Link; Mary E. Northridge; Jo C. Phelan; Michael L. Ganz
Since the early 1800s, studies have consistently demonstrated that people higher in the socioeconomic hierarchy live longer than people of lower rank. One hypothesis for the persistence of this association is that people who are relatively better off are more able to avoid risks by adopting currently available protective strategies. In a partial test of this idea, the social distributions of two cancer screening tests--Pap smears and mammography--were examined. A review of the literature and an analysis of Behavioral Risk Factor Surveillance System (BRFSS) data showed a consistent association between indicators of socioeconomic status and recent screening. These findings support the theory that societies create and shape patterns of disease. Innovations beneficial to health are carried out within the context of inequalities that shape the distribution of the health benefit, thereby affecting patterns of morality.
Urology | 2010
Michael L. Ganz; Amy Smalarz; Tracey L. Krupski; Jennifer T. Anger; Jim C. Hu; Kim Wittrup-Jensen; Chris L. Pashos
OBJECTIVES To calculate, from a societal perspective, current direct (medical and nonmedical) and indirect costs of overactive bladder (OAB) in the United States and project them to future years. Existing cost assessments of OAB in the United States are incomplete and outdated. METHODS A prevalence-based model was developed incorporating age- and sex-specific OAB prevalence rates, usage data, and productivity data. On the basis of the information gathered from the recent 5 years of the medical literature, practice guidelines, Medicare and managed care fee schedules, and expert panel input, the annual per capita and total US costs were calculated for 2007. US census population forecasts were used to project the costs of OAB to 2015 and 2020. RESULTS In 2007, average annual per capita costs of OAB were
Journal of General Internal Medicine | 2007
Laura A. McCloskey; Corrine M. Williams; Erika Lichter; Megan R. Gerber; Michael L. Ganz; Robert D. Sege
1925 (
Social Science & Medicine | 2011
Daniel Kim; Christopher F. Baum; Michael L. Ganz; S. V. Subramanian; Ichiro Kawachi
1433 in direct medical,
American Journal of Preventive Medicine | 1999
Robert E. Fullilove; Mindy Thompson Fullilove; Mary E. Northridge; Michael L. Ganz; Mary T. Bassett; Diane E. McLean; Angela Aidala; Donald H. Gemson; Colin McCord
66 in direct nonmedical, and
Public Health Reports | 2006
Laura A. McCloskey; Erika Lichter; Corrine M. Williams; Megan R. Gerber; Eve Wittenberg; Michael L. Ganz
426 in indirect costs). Applying these costs to the 34 million people in the United States with OAB results in total national costs of
Pediatrics | 2009
Beth M. McManus; Marie C. McCormick; Dolores Acevedo-Garcia; Michael L. Ganz; Penny Hauser-Cram
65.9 billion (billion = 1000 million), (
Pediatrics | 2006
Michael L. Ganz; Shalini A. Tendulkar
49.1 billion direct medical,
Ambulatory Pediatrics | 2002
Emily Davidson; Thomas J. Silva; Lisa A. Sofis; Michael L. Ganz; Judith S. Palfrey
2.3 billion direct nonmedical, and
Journal of the American Medical Informatics Association | 2010
Walter Palmas; Steven Shea; Justin Starren; Jeanne A. Teresi; Michael L. Ganz; Tanya Burton; Chris L. Pashos; Jan Blustein; Lesley Field; Philip C. Morin; Roberto Izquierdo; Stephanie Silver; Joseph P. Eimicke; Rafael Lantigua; Ruth S. Weinstock
14.6 billion indirect). Average annual per capita costs in 2015 and 2020 would be